Skip to main content
letter
. 2007 Sep;13(9):1436–1438. doi: 10.3201/eid1309.061446

Table. Epidemiologic characteristics, strain identification, and treatment of 21 cases of American cutaneous leishmaniasis, French Guiana, 2004–2005*.

Case no. Primary infection
Leishmaniasis recidiva cutis
Lesion(s), location (no.) PI treatment† Time to healed lesions, mo Disease-free interval, mo Direct examination Strain identification PI treatment Outcome
1 Thorax (1) IV, 4 mg/kg on alternate days × 3 1 4 + Leishmania guyanensis MON-45 IV, 4 mg/kg on alternate days × 4 Cured
2 Right forearm (1) IV, 4 mg/kg on alternate days × 3 3 6 + L. guyanensis MON-45 IV, 4 mg/kg on alternate days × 4 Cured
3 Left leg (1) and chin (3) IV, 4 mg/kg on alternate days × 3 1 4 + Negative culture IV, 4 mg/kg on alternate days × 4 Cured
4 Chin (3) IV, 4 mg/kg on alternate days × 3 1 4 + Negative culture IV, 4 mg/kg on alternate days × 4 Cured
5 Behind left ear (1) IV, 4 mg/kg on alternate days × 3 1 3 + L. guyanensis MON-131 IV, 4 mg/kg on alternate days × 4 Cured
6 Left ear (1) IV, 4 mg/kg on alternate days × 3 1 6 + Negative culture IV, 4 mg/kg on alternate days × 4 Cured
7 Right ankle (5) IV, 4 mg/kg on alternate days × 3 2.5 4 + Negative culture IV, 4 mg/kg on alternate days × 4 Cured
8–21 Various IV, 4 mg/kg on alternate days × 3 (for 9 patients) or IM, 4 mg/kg on alternate days × 2 (for 5 patients)† 1–3

*PI, pentamidine isethionate; IV, intravenous; IM, intramuscular.
†IV versus IM administration of pentamidine isethionate was not associated with recurrent forms.